Skip to main content
DM

DAMAE Medical

DAMAE Medical develops the deepLive™ imaging system, which utilizes line-field confocal optical coherence tomography (LC-OCT) technology to provide high-resolution, 3D imaging of skin lesions. This non-invasive method significantly reduces the rate of unnecessary biopsies and improves early detection of skin cancers, addressing the challenge of missed diagnoses in clinical practice.

Paris, France · HQ
Founded 2014335K+ followers
Updated 4 months ago

Funding

$5.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BP
Funding rounds are not available yet.

Founders

Product

Problem

Current methods for diagnosing skin cancer, such as dermoscopy, have limitations in sensitivity, leading to missed early-stage cancers and unnecessary biopsies of benign lesions. These diagnostic uncertainties can result in delayed treatment and increased patient morbidity.

Solution

DAMAE Medical's deepLive™ imaging system utilizes Line-field Confocal Optical Coherence Tomography (LC-OCT) to provide high-resolution, 3D imaging of skin lesions, offering a non-invasive alternative to traditional biopsy. The deepLive™ system allows clinicians to visualize skin structures at a cellular level, enabling more accurate differentiation between benign and malignant lesions. By providing detailed subsurface images, deepLive™ reduces the need for unnecessary biopsies and improves the early detection of skin cancers. The system's 3D imaging capabilities facilitate comprehensive assessment of skin conditions, promoting efficient and reassuring patient management.

Target Audience

The primary users are dermatologists, oncologists, and other medical professionals involved in skin cancer diagnosis and treatment, as well as research institutions focused on dermatology and oncology.

Features

  • Line-field Confocal Optical Coherence Tomography (LC-OCT) technology for high-resolution 3D imaging
  • Non-invasive imaging of skin lesions, reducing the need for biopsies
  • Vertical and horizontal imaging modes for comprehensive visualization
  • Quantitative skin analysis, including 3D segmentation of skin surface and dermo-epidermal junction
  • Analysis of keratinocyte distribution and density, as well as collagen fiber segmentation
  • Integration of live dermoscopic camera inside the LC-OCT 3D handheld probe
This profile is AI-generated and may contain inaccuracies.